Page 154 - Vitamin D and Cancer

6 Vitamin D: Cardiovascular Function and Disease 141

179. Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A (2007) Association of subclinical
vitamin D deficiency in newborns with acute lower respiratory infection and their mothers.
Eur J Clin Nutr 117:803–811
180. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki H, Ylikomi T (2007)
An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract
infection in young Finnish men. Am J Clin Nutr 86:714–717
181. Aloia JF, Li-Ng M (2007) Re: epidemic influenza and vitamin D. Epidemiol Infect
135:1095–1096, author reply 1097–1098
182. Muller K, Diamant M, Bendtzen K (1991) Inhibition of production and function of
interleukin-6 by 1, 25-dihydroxyvitamin D3. Immunol Lett 28:115–120
183. Willheim M, Thien R, Schrattbauer K, Bajna E, Holub M, Gruber R, Baier K, Pietschmann
P, Reinisch W, Scheiner O et al (1999) Regulatory effects of 1alpha, 25-dihydroxyvitamin
D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol
Metab 84:3739–3744
184. Zhu Y, Mahon BD, Froicu M, Cantorna MT (2005) Calcium and 1 alpha, 25-dihydroxyvita-
min D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease.
Eur J Immunol 35:217–224
185. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA (2001) 1-alpha,
25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active
immature dendritic cells from monocytes. Eur J Endocrinol 145:351–357
186. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B (2007) The effects of calcium and
vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic
adults. Diabetes Care 30:980–986
187. Simpson RU, Hershey SH, Nibbelink KA (2007) Characterization of heart size and blood
pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol
103:521–524
188. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC
(2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and
cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288:E125–132
189. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, Aganna
E, Price CP, Boucher BJ (2002) Circulating MMP9, vitamin D and variation in the TIMP-1
response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?
Qjm 95:787–796
190. Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci
WS, Sutherland P, Wilson PW et al (2004) Relations of plasma matrix metalloproteinase-9
to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the
Framingham Heart Study. Circulation 109:2850–2856
191. Duprez D, De Buyzere M, De Backer T, Clement D (1993) Relationship between vitamin D
and the regional blood flow and vascular resistance in moderate arterial hypertension.
J Hypertens Suppl 11:S304–305
192. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F
(2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role
of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613–620
193. Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, Arcaro G (2006) Serum
25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type
2 diabetic patients. Clin Endocrinol (Oxf) 65:593–597
194. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD (2008) Vitamin D improves
endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels.
Diabet Med 25:320–325
195. Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N, Hashimoto S, Itoh M (2006)
Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complica-
tions and type of treatment. Endocr J 53:503–510
196. Zieman SJ, Melenovsky V, Kass DA (2005) Mechanisms, pathophysiology, and therapy of
arterial stiffness. Arterioscler Thromb Vasc Biol 25:932–943